Nuzenio

Sonesitatug

Sonesitatug news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 12 publisher sources 100/100 entity strength

Latest news

AstraZeneca Drug Extends Survival in Advanced Gastric Cancer - MyChesCoMyChesCo · Sat, 08 Aug 2026 10:20:00 GMTPromising New Option for Claudin 18.2‑Positive Gastric and GEJ Cancer - news.cancerconnect.comnews.cancerconnect.com · Mon, 03 Aug 2026 17:25:49 GMTSonesitatug Vedotin Extends Survival in Advanced Gastric Cancer - Cure TodayCure Today · Wed, 29 Jul 2026 19:41:06 GMTKOL Views Preview: What to make of mixed survival data on AZ's Claudin18.2-targeting ADC in gastric cancer? - FirstWord PHARMAFirstWord PHARMA · Wed, 29 Jul 2026 03:15:19 GMTHong Kong-listed Keymed Biosciences’ gastric cancer drug meets late-stage trial goals - 1470 & 100.3 WMBD1470 & 100.3 WMBD · Tue, 28 Jul 2026 07:00:00 GMTAstraZeneca's Claudin 18.2-targeting ADC passes pivotal gastric cancer test - FirstWord PHARMAFirstWord PHARMA · Mon, 27 Jul 2026 20:25:00 GMTSonesitatug Vedotin Improves Survival in CLDN18.2-Positive Gastric Cancer - Targeted OncologyTargeted Oncology · Mon, 27 Jul 2026 16:08:21 GMTSonesitatug Vedotin Improves Overall Survival in CLDN18.2+ Gastric Cancer - CancerNetworkCancerNetwork · Mon, 27 Jul 2026 16:02:55 GMT

Timeline

Sat, 08 Aug 2026 10:20:00 GMTAstraZeneca Drug Extends Survival in Advanced Gastric Cancer - MyChesCo
Mon, 03 Aug 2026 17:25:49 GMTPromising New Option for Claudin 18.2‑Positive Gastric and GEJ Cancer - news.cancerconnect.com
Wed, 29 Jul 2026 19:41:06 GMTSonesitatug Vedotin Extends Survival in Advanced Gastric Cancer - Cure Today
Wed, 29 Jul 2026 03:15:19 GMTKOL Views Preview: What to make of mixed survival data on AZ's Claudin18.2-targeting ADC in gastric cancer? - FirstWord PHARMA
Tue, 28 Jul 2026 07:00:00 GMTHong Kong-listed Keymed Biosciences’ gastric cancer drug meets late-stage trial goals - 1470 & 100.3 WMBD
Mon, 27 Jul 2026 20:25:00 GMTAstraZeneca's Claudin 18.2-targeting ADC passes pivotal gastric cancer test - FirstWord PHARMA

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Sonesitatug.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.